Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FMZKX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,709
Award facts
- Contract value 100% obligated
- $1,709.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,709.46 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of DUPIXENT 300 mg/2 mL pens (2 mL quantity). The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award status. Performance is scheduled for completion by September 4, 2025, with the place of performance located in Conshohocken, Pennsylvania, the vendor's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in meeting federal medical procurement requirements through open competition. The company supplies a broad portfolio of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DUPIXENT (dupilumab) is a biologic medication used in the treatment of eczema, asthma, and other allergic conditions, reflecting the vendor's role in providing specialized therapeutic medications to support military and veteran healthcare needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FMZKX?
SPE2DB25FMZKX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FMZKX worth?
The government has obligated $1,709 on SPE2DB25FMZKX.
Is contract SPE2DB25FMZKX an order under another contract?
Yes. SPE2DB25FMZKX is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMZKX competed?
The extent of competition for SPE2DB25FMZKX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award